Alex Friedlaender

5PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsAutoimmunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 12, 2024
Metastatic gastric cancer: synergizing and sequencing targeted therapy with first-line immunotherapy.

Gina Colarusso, Hiba Mechahougui, Thibaud Koessler

|Mar 11, 2024
Management of stage III non-small-cell lung cancer: rays of hope.

Floryane Kim, Maxime Borgeaud, Alfredo Addeo

|Jun 02, 2021
KRAS G12C Mutations in NSCLC: From Target to Resistance.

Alfredo Addeo, Giuseppe Luigi Banna, Alex Friedlaender

|Apr 15, 2021
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.

Laure Thouvenin, Timothée Olivier, Giuseppe Banna

|Sep 05, 2020
The METeoric rise of MET in lung cancer.

Alex Friedlaender, Alexander Drilon, Giuseppe Luigi Banna

Pageof 1